rs80358908

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_000059.4(BRCA2):​c.6842G>A​(p.Gly2281Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000147 in 1,357,750 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G2281V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000015 ( 0 hom. )

Consequence

BRCA2
NM_000059.4 missense, splice_region

Scores

4
8
3
Splicing: ADA: 0.9992
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 3.70

Publications

14 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. Scorers claiming Uncertain: max_spliceai. No scorers claiming Benign.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
NM_000059.4
MANE Select
c.6842G>Ap.Gly2281Glu
missense splice_region
Exon 12 of 27NP_000050.3A0A7P0T9D7
BRCA2
NM_001432077.1
c.6842G>Ap.Gly2281Glu
missense splice_region
Exon 12 of 27NP_001419006.1A0A7P0T9D7
BRCA2
NM_001406720.1
c.6842G>Ap.Gly2281Glu
missense splice_region
Exon 12 of 27NP_001393649.1A0A8V8TPZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
ENST00000380152.8
TSL:5 MANE Select
c.6842G>Ap.Gly2281Glu
missense splice_region
Exon 12 of 27ENSP00000369497.3P51587
BRCA2
ENST00000544455.6
TSL:1
c.6842G>Ap.Gly2281Glu
missense splice_region
Exon 12 of 27ENSP00000439902.1P51587
BRCA2
ENST00000530893.7
TSL:1
c.6473G>Ap.Gly2158Glu
missense splice_region
Exon 12 of 27ENSP00000499438.2A0A590UJI7

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000408
AC:
1
AN:
244980
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000147
AC:
2
AN:
1357750
Hom.:
0
Cov.:
25
AF XY:
0.00
AC XY:
0
AN XY:
680324
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
30760
American (AMR)
AF:
0.00
AC:
0
AN:
43500
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25260
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39076
South Asian (SAS)
AF:
0.0000121
AC:
1
AN:
82458
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52920
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5498
European-Non Finnish (NFE)
AF:
9.79e-7
AC:
1
AN:
1021432
Other (OTH)
AF:
0.00
AC:
0
AN:
56846
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000203476), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.000861
Hom.:
0
ExAC
AF:
0.00000825
AC:
1

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Hereditary cancer-predisposing syndrome (2)
-
2
-
not provided (2)
-
1
-
Breast-ovarian cancer, familial, susceptibility to, 2 (1)
-
1
-
Hereditary breast ovarian cancer syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Uncertain
0.090
CADD
Pathogenic
26
DANN
Uncertain
1.0
Eigen
Uncertain
0.65
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.94
D
M_CAP
Pathogenic
0.45
D
MetaRNN
Uncertain
0.71
D
MetaSVM
Uncertain
0.44
D
PhyloP100
3.7
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.8
N
REVEL
Pathogenic
0.66
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0080
D
Vest4
0.49
MutPred
0.53
Gain of solvent accessibility (P = 0.0145)
MVP
0.95
MPC
0.18
ClinPred
0.96
D
GERP RS
5.0
gMVP
0.32
Mutation Taster
=54/46
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.90
SpliceAI score (max)
0.32
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.32
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80358908; hg19: chr13-32918695; API